IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v13y2022i1d10.1038_s41467-022-31510-1.html
   My bibliography  Save this article

Multi-modal molecular programs regulate melanoma cell state

Author

Listed:
  • Miles C. Andrews

    (Monash University
    The University of Texas MD Anderson Cancer Center)

  • Junna Oba

    (The University of Texas MD Anderson Cancer Center
    Keio University School of Medicine)

  • Chang-Jiun Wu

    (The University of Texas MD Anderson Cancer Center)

  • Haifeng Zhu

    (The University of Texas MD Anderson Cancer Center)

  • Tatiana Karpinets

    (The University of Texas MD Anderson Cancer Center)

  • Caitlin A. Creasy

    (The University of Texas MD Anderson Cancer Center)

  • Marie-Andrée Forget

    (The University of Texas MD Anderson Cancer Center)

  • Xiaoxing Yu

    (Keio University School of Medicine)

  • Xingzhi Song

    (The University of Texas MD Anderson Cancer Center)

  • Xizeng Mao

    (The University of Texas MD Anderson Cancer Center)

  • A. Gordon Robertson

    (Canada’s Michael Smith Genome Sciences Center, BC Cancer
    Dxige Research Inc.)

  • Gabriele Romano

    (The University of Texas MD Anderson Cancer Center)

  • Peng Li

    (The University of Texas MD Anderson Cancer Center)

  • Elizabeth M. Burton

    (The University of Texas MD Anderson Cancer Center)

  • Yiling Lu

    (The University of Texas MD Anderson Cancer Center)

  • Robert Szczepaniak Sloane

    (The University of Texas MD Anderson Cancer Center)

  • Khalida M. Wani

    (The University of Texas MD Anderson Cancer Center)

  • Kunal Rai

    (The University of Texas MD Anderson Cancer Center)

  • Alexander J. Lazar

    (The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center)

  • Lauren E. Haydu

    (The University of Texas MD Anderson Cancer Center)

  • Matias A. Bustos

    (Providence Saint John’s Health Center)

  • Jianjun Shen

    (The University of Texas MD Anderson Cancer Center)

  • Yueping Chen

    (The University of Texas MD Anderson Cancer Center)

  • Margaret B. Morgan

    (The University of Texas MD Anderson Cancer Center)

  • Jennifer A. Wargo

    (The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center)

  • Lawrence N. Kwong

    (The University of Texas MD Anderson Cancer Center)

  • Cara L. Haymaker

    (The University of Texas MD Anderson Cancer Center)

  • Elizabeth A. Grimm

    (The University of Texas MD Anderson Cancer Center)

  • Patrick Hwu

    (The University of Texas MD Anderson Cancer Center
    H Lee Moffitt Cancer Center)

  • Dave S. B. Hoon

    (Providence Saint John’s Health Center)

  • Jianhua Zhang

    (The University of Texas MD Anderson Cancer Center)

  • Jeffrey E. Gershenwald

    (The University of Texas MD Anderson Cancer Center)

  • Michael A. Davies

    (The University of Texas MD Anderson Cancer Center)

  • P. Andrew Futreal

    (The University of Texas MD Anderson Cancer Center)

  • Chantale Bernatchez

    (The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center)

  • Scott E. Woodman

    (The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center)

Abstract

Melanoma cells display distinct intrinsic phenotypic states. Here, we seek to characterize the molecular regulation of these states using multi-omic analyses of whole exome, transcriptome, microRNA, long non-coding RNA and DNA methylation data together with reverse-phase protein array data on a panel of 68 highly annotated early passage melanoma cell lines. We demonstrate that clearly defined cancer cell intrinsic transcriptomic programs are maintained in melanoma cells ex vivo and remain highly conserved within melanoma tumors, are associated with distinct immune features within tumors, and differentially correlate with checkpoint inhibitor and adoptive T cell therapy efficacy. Through integrative analyses we demonstrate highly complex multi-omic regulation of melanoma cell intrinsic programs that provide key insights into the molecular maintenance of phenotypic states. These findings have implications for cancer biology and the identification of new therapeutic strategies. Further, these deeply characterized cell lines will serve as an invaluable resource for future research in the field.

Suggested Citation

  • Miles C. Andrews & Junna Oba & Chang-Jiun Wu & Haifeng Zhu & Tatiana Karpinets & Caitlin A. Creasy & Marie-Andrée Forget & Xiaoxing Yu & Xingzhi Song & Xizeng Mao & A. Gordon Robertson & Gabriele Roma, 2022. "Multi-modal molecular programs regulate melanoma cell state," Nature Communications, Nature, vol. 13(1), pages 1-18, December.
  • Handle: RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-31510-1
    DOI: 10.1038/s41467-022-31510-1
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-022-31510-1
    File Function: Abstract
    Download Restriction: no

    File URL: https://libkey.io/10.1038/s41467-022-31510-1?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Rita Cabrita & Martin Lauss & Adriana Sanna & Marco Donia & Mathilde Skaarup Larsen & Shamik Mitra & Iva Johansson & Bengt Phung & Katja Harbst & Johan Vallon-Christersson & Alison Schoiack & Kristina, 2020. "Author Correction: Tertiary lymphoid structures improve immunotherapy and survival in melanoma," Nature, Nature, vol. 580(7801), pages 1-1, April.
    2. Dvir Aran & Marina Sirota & Atul J. Butte, 2015. "Systematic pan-cancer analysis of tumour purity," Nature Communications, Nature, vol. 6(1), pages 1-12, December.
    3. Florent Petitprez & Aurélien Reyniès & Emily Z. Keung & Tom Wei-Wu Chen & Cheng-Ming Sun & Julien Calderaro & Yung-Ming Jeng & Li-Ping Hsiao & Laetitia Lacroix & Antoine Bougoüin & Marco Moreira & Gui, 2020. "B cells are associated with survival and immunotherapy response in sarcoma," Nature, Nature, vol. 577(7791), pages 556-560, January.
    4. Yujin Hoshida & Jean-Philippe Brunet & Pablo Tamayo & Todd R Golub & Jill P Mesirov, 2007. "Subclass Mapping: Identifying Common Subtypes in Independent Disease Data Sets," PLOS ONE, Public Library of Science, vol. 2(11), pages 1-8, November.
    5. M. Bittner & P. Meltzer & Y. Chen & Y. Jiang & E. Seftor & M. Hendrix & M. Radmacher & R. Simon & Z. Yakhini & A. Ben-Dor & N. Sampas & E. Dougherty & E. Wang & F. Marincola & C. Gooden & J. Lueders &, 2000. "Molecular classification of cutaneous malignant melanoma by gene expression profiling," Nature, Nature, vol. 406(6795), pages 536-540, August.
    6. Levi A. Garraway & Hans R. Widlund & Mark A. Rubin & Gad Getz & Aaron J. Berger & Sridhar Ramaswamy & Rameen Beroukhim & Danny A. Milner & Scott R. Granter & Jinyan Du & Charles Lee & Stephan N. Wagne, 2005. "Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma," Nature, Nature, vol. 436(7047), pages 117-122, July.
    7. Cory M. Johannessen & Laura A. Johnson & Federica Piccioni & Aisha Townes & Dennie T. Frederick & Melanie K. Donahue & Rajiv Narayan & Keith T. Flaherty & Jennifer A. Wargo & David E. Root & Levi A. G, 2013. "A melanocyte lineage program confers resistance to MAP kinase pathway inhibition," Nature, Nature, vol. 504(7478), pages 138-142, December.
    8. Rita Cabrita & Martin Lauss & Adriana Sanna & Marco Donia & Mathilde Skaarup Larsen & Shamik Mitra & Iva Johansson & Bengt Phung & Katja Harbst & Johan Vallon-Christersson & Alison Schoiack & Kristina, 2020. "Tertiary lymphoid structures improve immunotherapy and survival in melanoma," Nature, Nature, vol. 577(7791), pages 561-565, January.
    9. Moshe Sade-Feldman & Yunxin J. Jiao & Jonathan H. Chen & Michael S. Rooney & Michal Barzily-Rokni & Jean-Pierre Eliane & Stacey L. Bjorgaard & Marc R. Hammond & Hans Vitzthum & Shauna M. Blackmon & De, 2017. "Resistance to checkpoint blockade therapy through inactivation of antigen presentation," Nature Communications, Nature, vol. 8(1), pages 1-11, December.
    10. Uri Ben-David & Benjamin Siranosian & Gavin Ha & Helen Tang & Yaara Oren & Kunihiko Hinohara & Craig A. Strathdee & Joshua Dempster & Nicholas J. Lyons & Robert Burns & Anwesha Nag & Guillaume Kugener, 2018. "Genetic and transcriptional evolution alters cancer cell line drug response," Nature, Nature, vol. 560(7718), pages 325-330, August.
    11. Judith Müller & Oscar Krijgsman & Jennifer Tsoi & Lidia Robert & Willy Hugo & Chunying Song & Xiangju Kong & Patricia A. Possik & Paulien D. M. Cornelissen-Steijger & Marnix H Geukes Foppen & Kristel , 2014. "Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma," Nature Communications, Nature, vol. 5(1), pages 1-15, December.
    12. Annelien Verfaillie & Hana Imrichova & Zeynep Kalender Atak & Michael Dewaele & Florian Rambow & Gert Hulselmans & Valerie Christiaens & Dmitry Svetlichnyy & Flavie Luciani & Laura Van den Mooter & So, 2015. "Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state," Nature Communications, Nature, vol. 6(1), pages 1-16, May.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Jia Wei & Xiaofeng Lu & Qin Liu & Yao Fu & Song Liu & Yang Zhao & Jiawei Zhou & Hui Chen & Meng Wang & Lin Li & Ju Yang & Fangcen Liu & Liming Zheng & Haitao Yin & Yang Yang & Chong Zhou & Ping Zeng &, 2023. "Neoadjuvant sintilimab in combination with concurrent chemoradiotherapy for locally advanced gastric or gastroesophageal junction adenocarcinoma: a single-arm phase 2 trial," Nature Communications, Nature, vol. 14(1), pages 1-12, December.
    2. Teresa Maria Rosaria Noviello & Anna Maria Giacomo & Francesca Pia Caruso & Alessia Covre & Roberta Mortarini & Giovanni Scala & Maria Claudia Costa & Sandra Coral & Wolf H. Fridman & Catherine Sautès, 2023. "Guadecitabine plus ipilimumab in unresectable melanoma: five-year follow-up and integrated multi-omic analysis in the phase 1b NIBIT-M4 trial," Nature Communications, Nature, vol. 14(1), pages 1-18, December.
    3. Nanda Horeweg & Hagma H. Workel & Dominik Loiero & David N. Church & Lisa Vermij & Alicia Léon-Castillo & Ricki T. Krog & Stephanie M. Boer & Remi A. Nout & Melanie E. Powell & Linda R. Mileshkin & He, 2022. "Tertiary lymphoid structures critical for prognosis in endometrial cancer patients," Nature Communications, Nature, vol. 13(1), pages 1-10, December.
    4. Mattia Rediti & Aranzazu Fernandez-Martinez & David Venet & Françoise Rothé & Katherine A. Hoadley & Joel S. Parker & Baljit Singh & Jordan D. Campbell & Karla V. Ballman & David W. Hillman & Eric P. , 2023. "Immunological and clinicopathological features predict HER2-positive breast cancer prognosis in the neoadjuvant NeoALTTO and CALGB 40601 randomized trials," Nature Communications, Nature, vol. 14(1), pages 1-18, December.
    5. Akshay J. Patel & Zena N. Willsmore & Naeem Khan & Alex Richter & Babu Naidu & Mark T. Drayson & Sophie Papa & Andrew Cope & Sophia N. Karagiannis & Esperanza Perucha & Gary W. Middleton, 2022. "Regulatory B cell repertoire defects predispose lung cancer patients to immune-related toxicity following checkpoint blockade," Nature Communications, Nature, vol. 13(1), pages 1-16, December.
    6. Li Yuan & Guo-Dong Jia & Xiao-Fei Lv & Si-Yi Xie & Shan-Shan Guo & Da-Feng Lin & Li-Ting Liu & Dong-Hua Luo & Yi-Fu Li & Shen-Wen Deng & Ling Guo & Mu-Sheng Zeng & Xiu-Yu Cai & Sai-Lan Liu & Xue-Song , 2023. "Camrelizumab combined with apatinib in patients with first-line platinum-resistant or PD-1 inhibitor resistant recurrent/metastatic nasopharyngeal carcinoma: a single-arm, phase 2 trial," Nature Communications, Nature, vol. 14(1), pages 1-17, December.
    7. Yoshito Yamada & Tuan Thanh Nguyen & Daniela Impellizzieri & Katsutaka Mineura & Rintaro Shibuya & Alvaro Gomariz & Martina Haberecker & Jakob Nilsson & César Nombela-Arrieta & Wolfgang Jungraithmayr , 2023. "Biased IL-2 signals induce Foxp3-rich pulmonary lymphoid structures and facilitate long-term lung allograft acceptance in mice," Nature Communications, Nature, vol. 14(1), pages 1-14, December.
    8. Matthew T. Campbell & Surena F. Matin & Alda L. Tam & Rahul A. Sheth & Kamran Ahrar & Rebecca S. Tidwell & Priya Rao & Jose A. Karam & Christopher G. Wood & Nizar M. Tannir & Eric Jonasch & Jianjun Ga, 2021. "Pilot study of Tremelimumab with and without cryoablation in patients with metastatic renal cell carcinoma," Nature Communications, Nature, vol. 12(1), pages 1-12, December.
    9. Zhenzhen Xun & Xinyu Ding & Yao Zhang & Benyan Zhang & Shujing Lai & Duowu Zou & Junke Zheng & Guoqiang Chen & Bing Su & Leng Han & Youqiong Ye, 2023. "Reconstruction of the tumor spatial microenvironment along the malignant-boundary-nonmalignant axis," Nature Communications, Nature, vol. 14(1), pages 1-16, December.
    10. Jae-Won Cho & Seyeon Park & Gamin Kim & Heonjong Han & Hyo Sup Shim & Sunhye Shin & Yong-Soo Bae & Seong Yong Park & Sang-Jun Ha & Insuk Lee & Hye Ryun Kim, 2021. "Dysregulation of TFH-B-TRM lymphocyte cooperation is associated with unfavorable anti-PD-1 responses in EGFR-mutant lung cancer," Nature Communications, Nature, vol. 12(1), pages 1-16, December.
    11. David Hsiehchen & Muhammad S. Beg & Radhika Kainthla & Jay Lohrey & Syed M. Kazmi & Leticia Khosama & Mary Claire Maxwell & Heather Kline & Courtney Katz & Asim Hassan & Naoto Kubota & Ellen Siglinsky, 2024. "The phosphatidylserine targeting antibody bavituximab plus pembrolizumab in unresectable hepatocellular carcinoma: a phase 2 trial," Nature Communications, Nature, vol. 15(1), pages 1-10, December.
    12. Lenka Kasikova & Jana Rakova & Michal Hensler & Tereza Lanickova & Jana Tomankova & Josef Pasulka & Jana Drozenova & Katerina Mojzisova & Anna Fialova & Sarka Vosahlikova & Jan Laco & Ales Ryska & Pav, 2024. "Tertiary lymphoid structures and B cells determine clinically relevant T cell phenotypes in ovarian cancer," Nature Communications, Nature, vol. 15(1), pages 1-19, December.
    13. Jianming Xu & Yi Li & Qingxia Fan & Yongqian Shu & Lei Yang & Tongjian Cui & Kangsheng Gu & Min Tao & Xiuwen Wang & Chengxu Cui & Nong Xu & Juxiang Xiao & Quanli Gao & Yunpeng Liu & Tao Zhang & Yuxian, 2022. "Clinical and biomarker analyses of sintilimab versus chemotherapy as second-line therapy for advanced or metastatic esophageal squamous cell carcinoma: a randomized, open-label phase 2 study (ORIENT-2," Nature Communications, Nature, vol. 13(1), pages 1-12, December.
    14. Martin Lauss & Bengt Phung & Troels Holz Borch & Katja Harbst & Kamila Kaminska & Anna Ebbesson & Ingrid Hedenfalk & Joan Yuan & Kari Nielsen & Christian Ingvar & Ana Carneiro & Karolin Isaksson & Kri, 2024. "Molecular patterns of resistance to immune checkpoint blockade in melanoma," Nature Communications, Nature, vol. 15(1), pages 1-14, December.
    15. Aditi Sahu & Kivanc Kose & Lukas Kraehenbuehl & Candice Byers & Aliya Holland & Teguru Tembo & Anthony Santella & Anabel Alfonso & Madison Li & Miguel Cordova & Melissa Gill & Christi Fox & Salvador G, 2022. "In vivo tumor immune microenvironment phenotypes correlate with inflammation and vasculature to predict immunotherapy response," Nature Communications, Nature, vol. 13(1), pages 1-19, December.
    16. Yang Chen & Keren Jia & Yu Sun & Cheng Zhang & Yilin Li & Li Zhang & Zifan Chen & Jiangdong Zhang & Yajie Hu & Jiajia Yuan & Xingwang Zhao & Yanyan Li & Jifang Gong & Bin Dong & Xiaotian Zhang & Jian , 2022. "Predicting response to immunotherapy in gastric cancer via multi-dimensional analyses of the tumour immune microenvironment," Nature Communications, Nature, vol. 13(1), pages 1-12, December.
    17. Soizic Garaud & Marie-Caroline Dieu-Nosjean & Karen Willard-Gallo, 2022. "T follicular helper and B cell crosstalk in tertiary lymphoid structures and cancer immunotherapy," Nature Communications, Nature, vol. 13(1), pages 1-4, December.
    18. Rana Falahat & Anders Berglund & Patricio Perez-Villarroel & Ryan M. Putney & Imene Hamaidi & Sungjune Kim & Shari Pilon-Thomas & Glen N. Barber & James J. Mulé, 2023. "Epigenetic state determines the in vivo efficacy of STING agonist therapy," Nature Communications, Nature, vol. 14(1), pages 1-16, December.
    19. Caroline Hoffmann & Floriane Noel & Maximilien Grandclaudon & Lucile Massenet-Regad & Paula Michea & Philemon Sirven & Lilith Faucheux & Aurore Surun & Olivier Lantz & Mylene Bohec & Jian Ye & Weihua , 2022. "PD-L1 and ICOSL discriminate human Secretory and Helper dendritic cells in cancer, allergy and autoimmunity," Nature Communications, Nature, vol. 13(1), pages 1-20, December.
    20. Pakavarin Louphrasitthiphol & Alessia Loffreda & Vivian Pogenberg & Sarah Picaud & Alexander Schepsky & Hans Friedrichsen & Zhiqiang Zeng & Anahita Lashgari & Benjamin Thomas & E. Elizabeth Patton & M, 2023. "Acetylation reprograms MITF target selectivity and residence time," Nature Communications, Nature, vol. 14(1), pages 1-15, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-31510-1. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.